OpenVSafe by OpenVAERS
Search V-safe

5QH-27199-45827

3 vaccinations 3 coded responses 11 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
480 / MI
Registered
2021-02-09
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-05
    Dose 1 — Moderna
  2. 2021-02-02
    Dose 2 — Moderna
  3. 2021-02-09
    Registered in v-safe
  4. 2021-02-09
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-02-16
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  6. 2021-02-23
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  7. 2021-03-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-03-09
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-03-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-05-04
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-08-03
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-08-25
    Dose 3 — Moderna
  13. 2021-11-26
    Survey response — 3 months, dose 3
    MedDRA: Pregnancy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Pregnancy
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-11-26
    Report sent to call center — 3 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  15. 2021-11-30
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  16. 2022-02-23
    Survey response — 6 months, dose 3
    MedDRA: Foetal growth restriction, Pregnancy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Acid reflux. High risk pregnancy with restricted fetal growth
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-02-23
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  18. 2022-02-25
    Call successful
    Participant prefers to complete VAERS report online
  19. 2022-08-28
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: COVID during pregnancy
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-08-28
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  21. 2022-08-29
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-01-05Moderna
22021-02-02Moderna
32021-08-25Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2021-11-26 Successful
2021-11-30
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-02-23 Successful
2022-02-25
Participant prefers to complete VAERS report online
2022-08-28 Successful
2022-08-29
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 10 — 3 months, dose 3

2021-11-26

Symptoms: Pregnancy

Release 11 — 6 months, dose 3

2022-02-23

Symptoms: Acid reflux. High risk pregnancy with restricted fetal growth

Release 12 — 12 months, dose 3

2022-08-28

Symptoms: COVID during pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDFoetal growth restriction · · ✓
SDPregnancy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release